Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
For more than three decades, acetaminophen (INN, paracetamol) has been claimed to be devoid of significant inhibition of peripheral prostanoids. Meanwhile, attempts to explain its action by inhibition of a central cyclooxygenase (COX)‐3 have been rejected. The fact that acetaminophen acts functionally as a selective COX‐2 inhibitor led us to investigate the hypothesis of whether it works via preferential COX‐2 blockade. Ex vivo COX inhibition and pharma‐cokinetics of acetaminophen were assessed in 5 volunteers receiving single 1000 mg doses orally. Coagulation‐induced thromboxane B 2 and lipopolysaccharide‐induced prostaglandin E 2 were measured ex vivo and in vitro in human whole blood as indices of COX‐1 and COX‐2 activity. In vitro , acetaminophen elicited a 4.4‐fold selectivity toward COX‐2 inhibition (IC 50 = 113.7 μmol/L for COX‐1;IC 50 = 25.8 μmol/L for COX‐2). Following oral administration of the drug, maximal ex vivo inhibitions were 56% (COX‐1) and 83% (COX‐2). Acetaminophen plasma concentrations remained above the in vitro IC 50 for COX‐2 for at least 5 h postadministration. Ex vivo IC 50 values (COX‐1: 105.2 μmol/L; COX‐2: 26.3 μmol/L) of acetaminophen compared favorably with its in vitro IC 50 values. In contrast to previous concepts, acetaminophen inhibited COX‐2 by more than 80%, i.e. , to a degree comparable to nonste‐roidal antiinflammatory drugs (NSAIDs) and selective COX‐2 inhibitors. However, a >95% COX‐1 blockade relevant for suppression of platelet function was not achieved. Our data may explain acetaminophen's analgesic and antiinflammatory action as well as its superior overall gastrointestinal safety profile compared with NSAIDs. In view of its substantial COX‐2 inhibition, recently defined cardiovascular warnings for use of COX‐2 inhibitors should also be considered for acetaminophen.—Hinz, B., Cheremina, O., Brune, K. Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man. FASEB J. 22, 383–390 (2007)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hinz et al. (2007) demonstrated 4.4x more selectivity toward the inhibition of COX-2 (IC 50 = 25.8 µmol/L) over COX-1 (IC 50 = 113.7 µmol/ L) from in vitro assays using whole human blood [51].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
In the citing paper
“In this study, paracetamol demonstrated over 80% blockade of COX-2 activity comparable to NSAIDs and COX-2 selective inhibitors.”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
In the citing paper
“It is not clear why there are significant discrepancies in relation to inhibition of COX-1 and COX-2 activities by paracetamol as reported by Hinz et al. [51] and Mitchell et al. [33].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
Citations
Cites
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989 · cited 2×
“Attempts to explain the pharmacological action of acetaminophen as inhibition of a central COX isoform, derived from the same gene as COX-1 and referred to as COX-3 (8), have been meanwhile rejected for several reasons (9).”
BackgroundCyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
The antioxidants of human extracellular fluids
Halliwell, B., & Gutteridge, J. M. C. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90510-6 · Cited by 1,341 · cited 1×
“Thus, the presence of various enzymatic and nonenzymatic antioxidant components in human plasma (33) may explain why acetaminophen elicited the most pronounced COX-2 inhibition in human whole blood as compared to the two other experimental systems.”
ResultSerhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189 · cited 1×
“Apart from these factors, evidence for COX-2 inhibition by acetaminophen is also supported by previous findings showing that acetaminophen like indomethacin and aspirin confers the synthesis of 18R-hydroxyeicosapentaenoic acid (HEPE) and 15RHEPE through interaction with the COX-2 enzyme (34).”
ResultLangenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123 · cited 1×
“A COXindependent mechanism for the gastrointestinal toxicity of NSAIDs is further supported by findings in COX-1 knockout mice, which still develop gastric erosions in response to oral administration of indomethacin (45).”
BackgroundPharmacological analysis of cyclooxygenase-1 in inflammation
Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13313 · Cited by 807 · cited 2×
“A peripheral antiinflammatory action is further supported by findings showing acetaminophen as an inhibitor of nociception and edema in the rat carrageenan footpad model (27, 28), an inflammatory condition critically dependent on COX-2-derived PGs (29).”
BackgroundFLOWER, R. J., & VANE, J. R. (1972) · Nature · doi:10.1038/240410a0 · Cited by 779 · cited 2×
“Whereas the drug was first associated with a predominant suppression of PG synthesis in brain tissue ( 3 ), subsequent studies contradicted a cell-specific modulation (4 –7).”
BackgroundMethodMechanism of Action of Paracetamol
Graham, G. G., & Scott, K. F. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00008 · Cited by 648 · cited 4×
“Moreover, it turned out that acetaminophen elicits no measurable inhibition of PG formation in broken cell preparations but a profound suppression in intact cells (7).”
BackgroundInfluentialNonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years
Wallace, J. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041264 · Cited by 569
Cannon, C. P., Curtis, S. P., FitzGerald, G. A., Krum, H., Kaur, A., Bolognese, J. A., Reicin, A. S., Bombardier, C., Weinblatt, M. E., van der Heijde, D., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69666-9 · Cited by 522 · cited 1×
“PGE2 is the currently most plausible explanation for the cardiovascular hazard conferred by selective and nonselective COX-2 inhibitors (20, 30).”
Background
Research works printed but not linked: 1
- Mantzke U. S., 2002, Paracetamol in childhood. Current state of knowledge and indications for a rational approach to postoperative analgesia, Anaesthesist, 51, 735
Cited by
Items 301–400 of 489
Yi, X., Xie, B., Hu, Y. J., Gong, T.-J., Chen, M., & Cui, X.-J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1445975 · Cited by 5
“Compared with NSAIDs, acetaminophen has higher overall gastrointestinal safety (Hinz et al., 2008).”
BackgroundKaur, A., Rehman, H. M., Mishra, V. K., Kaur, G., Kaur, M., Okla, M. K., Shah, M., & Bansal, M. (2025) · RSC Medicinal Chemistry · doi:10.1039/d4md00751d · Cited by 6
Tsuchiya, H., & Mizogami, M. (2025) · Future Pharmacology · doi:10.3390/futurepharmacol5030040 · Cited by 9
“Although acetaminophen is an inhibitor selective for COX-2, its potency to inhibit COX-2 is weaker than that of diclofenac, ibuprofen, and other NSAIDs as shown by the IC 50 values for COX-2 in Figure 4, which was prepared by using reported data [25–27 ,29 ,30, 32 , 33 ].”
InfluentialPerianale und rektale Ulzera nach Abusus von Paracetamol-Codein-Suppositorien
Wagner, G. F., Sand, C., & Sachse, M. M. (2014) · Der Hautarzt · doi:10.1007/s00105-014-3534-4 · Cited by 5
Pharmacology of paracetamol and prescribing considerations
Bennett, S. (2013) · Nurse Prescribing · doi:10.12968/npre.2013.11.1.28 · Cited by 5
NSAIDs in the acute pain treatment from the viewpoint of a neurologist
Nežádal, T. (2017) · Medicína pro praxi · doi:10.36290/med.2017.026 · Cited by 7
Kinsey, T. L., Stürmer, T., Funk, M. J., Poole, C., Simpson, R. J., & Glynn, R. J. (2019) · Rheumatology · doi:10.1093/rheumatology/kez653 · Cited by 5
Ayyad, R. R. A., & Sakr, H. M. (2016) · Medicinal Chemistry · doi:10.4172/2161-0444.1000360 · Cited by 5
“In the view of these facts and to develop earlier reporting [6] quinazoline-4(3H)-ones series that drawn great attention in the field of synthetic medicinal chemistry because it shown good analgesic and anti-inflammatory activities therefore, our aim was oriented to design derivatives of existing clinically used NSAID…”
BackgroundVahdati, S. S., Robaei, N., Habibollah, P., Jafari-Rouhi, A., Mohammadi, S., & Piri, R. (2018) · Nephro-Urology Monthly · doi:10.5812/numonthly.77193 · Cited by 5
COX‐2 inhibitors show no preventive effect in the development of skin cancer
Yen, H., Yen, H., Drucker, A. M., Han, J., Li, W., Li, T., Qureshi, A. A., & Cho, E. (2022) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14649 · Cited by 5
Nilsson, J. L. Å., Blomgren, A., Nilsson, U. J., Högestätt, E. D., & Grundemar, L. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13058 · Cited by 5
Fischer, J., Ganellin, C. R., Ganesan, A., & Proudfoot, J. (2010) · Wiley eBooks · doi:10.1002/9783527630035.ch2 · Cited by 8
Yoon, S., Cho, S., Lee, H., Yoon, S., & Bahk, J. (2025) · The Korean journal of pain · doi:10.3344/kjp.25308 · Cited by 4
“Acetaminophen exerts its analgesic effect mainly via central modulation of pain pathways, while ibuprofen provides peripheral anti-inflammatory effects [13].”
Mittal, T., Badhe, V. K., Badhe, D. D., Ahluwalia, P., Mittal, B., & Mittal, R. (2024) · Anaesthesia Pain & Intensive Care · doi:10.35975/apic.v28i1.2380 · Cited by 4
“17 They act primarily in peripheral tissues to inhibit the formation of pain-producing substances such as prostaglandins.”
BackgroundAboshama, M., Abdo, W. S., El-Sawak, A., & Khater, A. (2024) · Open Veterinary Journal · doi:10.5455/ovj.2024.v14.i1.28 · Cited by 5
Non‐Steroidal Anti‐Inflammatory Drugs
Papich, M. G. (2024) · Wiley eBooks · doi:10.1002/9781119830306.ch24 · Cited by 5
Synthesis, hydrolysis, and COX-2/15-LOX inhibitory evaluation of 4-Acetamidophenyl 4-Bromobenzoates
Afzal, U., Mahmood, A., Zubaır, M., Rasool, N., Kanwal, A., Sohail, M., & Ahmad, G. (2025) · Medicinal Chemistry Research · doi:10.1007/s00044-025-03393-6 · Cited by 4
“It is well known that acetaminophen (paracetamol) selectively inhibits COX-2 in humans [18].”
Saraswatarishta reverses neuronal injury in brain tissues of scopolamine-induced rat model
Jayakumari, S., Prabhu, J., Prabhu, K., Kumar, J. A., Subramanian, M., & Kavimani (2019) · Journal of Anatomical Society of India · doi:10.4103/jasi.jasi_45_19 · Cited by 6
“There are various medicines to treat neuronal inflammation such as nonsteroidal anti‐inflammatory drugs (NSAIDS), opioid antagonists, selective cyclooxygenase inhibitor, N‐methyl‐D‐aspartate receptor antagonists, and occasionally antibiotics.[1,2] However, those allopathic drugs are efficient to relive analgesia and i…”
BackgroundParacetamol preceding very preterm birth: Is it safe?
Laitala, A., Saarela, T., Vääräsmäki, M., Hallman, M., & Aikio, O. (2022) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14405 · Cited by 4
Gunjal, R., Gajbhar, A. V., Vichare, V. S., Sutar, A. S., Deshmukh, M. P., & Choudhari, V. P. (2022) · Biomedical and Biotechnology Research Journal (BBRJ) · doi:10.4103/bbrj.bbrj_92_22 · Cited by 4
Pasi, R., Babu, T. A., & Kallidoss, V. K. (2023) · Therapeutic Advances in Vaccines and Immunotherapy · doi:10.1177/25151355231216122 · Cited by 4
“25,26 The analgesic effect of paracetamol is of low potency to produce pharmacological effects through peripheral COX-1 blockage, which might explain its statistical insignificance as compared to placebo.”
BackgroundParacetamol: Wirksam und sicher bis ins hohe Alter
Wehling, M. (2012) · Der Schmerz · doi:10.1007/s00482-012-1270-1 · Cited by 4
SHARMA, S., Pareek, A., Joshi, R., Ratan, Y., JAIN, V., & Jadon, G. (2013) · Oriental Journal Of Chemistry · doi:10.13005/ojc/290261 · Cited by 4
Nonprescription Analgesic Anti-inflammatory Drugs: Efficacy and Safety
McCarthy, D. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-33889-7_8 · Cited by 4
Multimodal Frequency Treatment for Facial Pain Caused by Chronic Rhinosinusitis: A Pilot Study
Smith, M. A., Berenger, P., Bonutti, P. M., Ramakrishnan, A., Beyers, J., & Ramakrishnan, V. (2017) · Sinusitis · doi:10.3390/sinusitis2030005 · Cited by 4
“Common pain relievers are also used [12].”
Pain Management in Patients with Impaired Kidney Function
Mirishova, S., & Hammad, Y. M. H. A. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.81695 · Cited by 4
Krisnamurti, G. C., & Fatchiyah, F. (2019) · Journal of Physics, Conference Series · doi:10.1088/1742-6596/1146/1/012004 · Cited by 5
Perioperative Schmerztherapie mit Nichtopioidanalgetika
Stamer, U., Erlenwein, J., Freys, S., Stammschulte, T., Stichtenoth, D., & Wirz, S. (2021) · Der Anaesthesist · doi:10.1007/s00101-021-01010-w · Cited by 3
Messerer, B., Grögl, G., Stromer, W., & Jaksch, W. (2014) · Der Schmerz · doi:10.1007/s00482-014-1419-1 · Cited by 4
Zhou, T., Shen, Y., Lyu, J., Li, Y., Wang, H., Hong, S., & Ji, Y. (2024) · Healthcare · doi:10.3390/healthcare12070713 · Cited by 3
“Prostaglandin D2 is an important influence on brain development and function [58].”
BackgroundInfluentialMahagna, A. A., Annunziata, S., Torriani, C., Jannelli, E., Mascia, B., Montagna, A., Mosconi, M., Mattia, C., & Pasta, G. (2024) · Healthcare · doi:10.3390/healthcare12192007 · Cited by 3
“When overdosed multiple times, paracetamol has a hepatotoxic effect, and so the approved maximum individual dosage of 15 mg/kg of body weight or maximum individual dosage of 1 g and maximum daily dosage of 4 g for people weighing >50 kg should never be exceeded [17].”
BackgroundKang, M., & An, S. A. (2010) · Toxicology and Environmental Health Sciences · doi:10.1007/bf03217495 · Cited by 4
Polat, R., Akın, M., Keskin, G., Ünal, D., & Dönmez, A. (2016) · Türk anesteziyoloji ve reanimasyon derneği dergisi · doi:10.5152/tjar.2016.20981 · Cited by 3
“Parasetamol’ün anti-nosiseptif etkisini, hem santral hem de periferik siklooksijenaz-2 (COX2) inhibisyonu ile sağladığını gösteren çalışmalar vardır (7-9).”
Sajadi, M. M., & Mackowiak, P. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00067-8 · Cited by 3
Alorfi, N. M. (2023) · Bulletin of Pharmaceutical Sciences Assiut · doi:10.21608/bfsa.2023.199161.1686 · Cited by 5
Tran‐Guzman, A., Khan, A., & Culty, M. (2023) · Andrology · doi:10.1111/andr.13537 · Cited by 3
Arabzadeh, S., Zeinoddini, A., Mostafavi, S., Hamedi, M., Ehyaii, A., Ghaleiha, A., Zeinoddini, A., & Akhondzadeh, S. (2018) · PubMed Central · Cited by 4
Omotayo, R., Faturoti, S., Ehinmitan, R., & Alao, F. O. (2018) · Tropical Journal of Obstetrics and Gynaecology · doi:10.4103/tjog.tjog_33_18 · Cited by 3
“The main mechanism proposed is the inhibition of cyclooxygenase (COX), and recent findings suggest that it is highly selective for COX-2.[24]”
BackgroundGreener, M. (2009) · Nurse Prescribing · doi:10.12968/npre.2009.7.9.43999 · Cited by 3
Aytar, E. C., Çalışkan, M., Çalışkan, S. Ö., Gümrükçüoğlu, A., Torunoğlu, E. İ., & Doğu, S. (2026) · Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology · doi:10.1007/s44473-026-00105-9 · Cited by 2
“Cyclooxygenase-2 (COX-2, PTGS2) can be considered an enzyme that plays an important role in tumor progression and may be involved in the development of various cancers, including colorectal cancer (Hinz et al. 2008; Sathishkumar et al. 2022).”
Andryszkiewicz, W., Lippik, M., Makieła, M., Modrzyk, B., & Gomułka, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093727 · Cited by 2
“In clinical practice, low-dose paracetamol ( 500 mg) may be utilized as an alternative analgesic because of its neutral pH and weak COX-1 inhibition, which prevents the gas-https trointestinal toxicity, platelet dysfunction, and bronchospastic risks associated with acidic NSAIDs [56].”
Synthesis of New Acetaminophen Analogs and Their Ibuprofen Conjugates as Novel Analgesic Drugs
Ahmadi, A., Khalili, M., Sadeghi, S., Soleimani, N., & Nahri-Niknafs, B. (2016) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-016-1454-6 · Cited by 2
Moreno‐Ajona, D., Martínez, M. D. V., Chan, C., & Goadsby, P. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00083-9 · Cited by 2
Optimal Timing of Intravenous Acetaminophen Administration for Postoperative Analgesia
Shinoda, M., Nishimura, A., Sugiyama, E., Sato, H., & Iijima, T. (2022) · Anesthesia Progress · doi:10.2344/anpr-69-02-05 · Cited by 2
Chourasia, A., & Lodhi, S. (2024) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2024.160413 · Cited by 2
Borah, B., & Saikia, J. (2024) · Spectroscopy Letters · doi:10.1080/00387010.2024.2400972 · Cited by 2
Binarani, M., Singh, Y., Lairenlakpam, D., Singh, S., Eshori, L., & Sinam, N. (2017) · Journal of Medical Society · doi:10.4103/0972-4958.204828 · Cited by 2
Nutraceutical Alternatives to Pharmaceutical Analgesics in Osteoarthritis
Heffernan, S. M., & Conway, G. E. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95919 · Cited by 2
Treating Pain and Inflammation in Hypertension
White, W. B., Marfatia, R., & Baker, W. L. (2012) · Springer eBooks · doi:10.1007/978-88-470-2601-8_28 · Cited by 3
“The drug acts to reduce active oxidized COX to an inactive form, unlike traditional NSAIDs and selective COX-2 inhibitors, which inhibit COX by competing with arachidonic acid [46, 47].”
BackgroundSafety of Oral Paracetamol – Analysis of Data from a Spontaneous Reporting System in Poland
Han, S., Kuchar, E. P., Karłowicz-Bodalska, K., Kutycka, E., Miśkiewicz, K., & Nitsch-Osuch, A. S. (2014) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v13i4.20 · Cited by 2
“NAPQI and acts as an agonist of TRPA1-receptors in the spinal cord, which suppresses the pain transduction [4,5].”
BackgroundMerritt, C. K., Salinas, O. J., & Kaye, A. D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0909-4_6 · Cited by 2
Schindler, R., & Brunner-, L. (2009) · Swiss Medical Weekly · doi:10.4414/smw.2009.12501 · Cited by 2
EFFECT OF CORN SILK EXTRACT ON ACETAMINOPHEN INDUCED RENAL DAMAGE IN MICE
Mehboob, F., & Tahir, M. (2015) · Pakistan Armed Forces Medical Journal · Cited by 2
Pharmacological agents for bone remodeling
Seifi, M., Amdjadi, P., & Tayebi, L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100961-1.00028-1 · Cited by 2
Ali, Z., Singh, S., Hassan, N., & Naqash, I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805299-0.00051-8 · Cited by 2
Ben-Hander, G. M., Gaeth, M. E., & Otmaan, N. A. (2022) · Sirte Journal of Medical Sciences · doi:10.37375/sjms.v1i2.322 · Cited by 5
Turones, L. C., Machado, L. S., Vaz, B. G., Oliveira, G. D. A. R., Moreira, L. K. D. S., Almeida, D. D. S., Martins, A. N., Fajemiroye, J. O., Martins, J. L. R., Ghedini, P. C., et al. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01324-8 · Cited by 2
“Due to the weak ability of paracetamol to inhibit the synthesis of PGs and other eicosanoids produced by COXs in most tissues (Hinz et al. 2008; Ghanem et al. 2016), our findings regarding that in a repeated treat-ment, paracetamol cause a similar histopathological impairment in the kidney as other…”
Simon, J. P., Namashivayam, A., Katturajan, R., Nithiyanandam, S., Manisha, P., & Prince, S. E. (2022) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.56.2.81 · Cited by 1
Skubatz, H. (2022) · Plant Biology · doi:10.1111/plb.13466 · Cited by 1
Burger, N., Bosmans, T., Bhatti, S. F. M., Ooms, S., Broeckx, B. J. G., Polis, I., Ham, L. V., & Cornelis, I. (2023) · Vlaams Diergeneeskundig Tijdschrift · doi:10.21825/vdt.90044 · Cited by 1
Nonsteroidal Anti-Inflammatory Drug Leads from Plant Sources
Sharanya, C. S., & Natarajan, K. (2024) · Springer eBooks · doi:10.1007/978-981-99-9183-9_8 · Cited by 2
Чуйкова, П. О., & Штриголь, С. Ю. (2025) · Pharmacology and Drug Toxicology · doi:10.33250/19.01.068 · Cited by 1
Anti-Inflammatory Activity of 1,2-Benzothiazine 1,1-Dioxide Derivatives
Szczęśniak-Sięga, B. M., & Topolska, I. (2025) · Pharmaceuticals · doi:10.3390/ph18101484 · Cited by 1
“The COX-3 isoform has been identified as a “spliced” variant of COX-1 and is mainly present in the brain and spinal cord [65–67].”
Zamri, N. I., Ngo, H. C., Court, E., Samaranayake, L. P., Fakhruddin, K. S., Amaechi, B. T., & Khani, S. (2026) · International Dental Journal · doi:10.1016/j.identj.2026.109478 · Cited by 1
“45,46 The findings of Serna Mu ~ noz et al 24 reported here demonstrate medium to high level suppression of COX2 by ibuprofen and acetaminophen in rats, affecting enamel mineralization.”
Interacción warfarina y acetaminofén: Evaluación para establecer su relevancia clínica
Ceballos, M., Holguín, H., González, C., & Amariles, P. (2013) · Acta Médica Colombiana · doi:10.36104/amc.2013.228 · Cited by 1
Tabassum, A., Saha, R., Rahman, M. S., Nure, M. A., Karim, R., Imon, A. H. M. R., Maniruzzam, M., Kabir, A.-U., Islam, A., Chaity, J. F., et al. (2016) · Journal of Pharmacology and Toxicology · doi:10.3923/jpt.2017.1.13 · Cited by 1
Paracetamol as a basic component of a modern approach to adequate perioperative analgesia
Zakalska, K., & Babiichuk, O. (2020) · Pain medicine · doi:10.31636/pmjua.v5i1.2 · Cited by 1
Pharmacogenetics of Pain Medication
Lötsch, J. (2012) · Wiley eBooks · doi:10.1002/9781118116494.ch12 · Cited by 1
Isiordia‐Espinoza, M. A., Tiznado‐Orozco, G. E., & Pozos‐Guillén, A. (2013) · Drug Development Research · doi:10.1002/ddr.21081 · Cited by 1
“Its mechanism of analgesic action has been related to the inhibition of the putative cyclooxygenase (COX)-3 enzyme in the central nervous system (CNS), but other evidence suggests that the reduction of prostaglandin synthesis caused by inhibition of peripheral COX-2 could be its main mechanism of action [Botting and A…”
BackgroundThippeswamy, M., Prabhakara, S., Krishnan, P., Bhandare, B., & Sahajanand, H. (2015) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 1
Ali, Z., & Prabhakar, H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804075-1.00031-6 · Cited by 1
Pharmacology and prescribing of paracetamol: an update
Bennett, S. (2016) · Nurse Prescribing · doi:10.12968/npre.2016.14.9.450 · Cited by 1
Toxic to the Heart: Target Organ Toxicity and NMR Spectroscopy of NSAIDs
Barcena, H. S. (2016) · ACS symposium series · doi:10.1021/bk-2016-1233.ch009 · Cited by 1
Sebastián, S., Vela, C., & Meneses, L. (2017) · Revista Ecuatoriana de Medicina y Ciencias Biológicas · doi:10.26807/remcb.v38i2.546 · Cited by 1
“…equipo mostraron que luego de la administración oral de paracetamol, se encontraron inhibiciones máximas de 56 % para la COX-1 y 83 % para la COX-2 (Hinz et al. 2008), aunque in vivo, el paracetamol se elimina rápidamente, por lo que la inhibición de la COX-2 es baja debido a la corta vida media…”
BackgroundA Review of Perioperative Analgesic Strategies in Cardiac Surgery
Chanowski, E. J. P., Ismawan, J. M., & Oakes, D. A. (2018) · International Anesthesiology Clinics · doi:10.1097/aia.0000000000000200 · Cited by 1
Cyclooxygenase (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Izzo, A. A., & Mitchell, J. A. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f269/2019.4 · Cited by 1
Eicosanoid turnover (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database
Izzo, A. A., & Mitchell, J. A. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f243/2019.5 · Cited by 1
Anti-arrhythmic Effects of Non-anti-arrhythmic Drugs or Therapies
Li, K. H. C., Tse, G., Liu, T., & Yan, G. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-41967-7_26 · Cited by 1
Nichtopioidanalgetika in der Anästhesiologie
Brack, A., & Schäfer, M. (2016) · Springer eBooks · doi:10.1007/978-3-662-45539-5_21-1 · Cited by 2
Silverman, J., & Gulati, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-18005-8_28 · Cited by 2
Schmerztherapie mit Nicht-Opioiden
Beubler, E. (2020) · Springer eBooks · doi:10.1007/978-3-662-60346-8_3 · Cited by 1
Cyclooxygenase in GtoPdb v.2023.1
Izzo, A. A., & Mitchell, J. A. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f269/2023.1 · Cited by 1
Paracetamol and unwanted 5‐hydroxytryptamine interactions
Kidd, L., & Milner, Q. J. W. (2015) · Anaesthesia · doi:10.1111/anae.13112 · Cited by 1
Dual Carbonic Anhydrase and Cyclooxygenase‐2 Inhibition
Dogné, J., Thiry, A., Masereel, B., & Supuran, C. T. (2009) · Wiley eBooks · doi:10.1002/9780470508169.ch11 · Cited by 1
Uncertain risks of drug related harms, the precautionary principle and limitations of meta‐analysis
Ritter, J. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03553.x · Cited by 1
Control of analgesic and anti-inflammatory pathways by fatty acid amide hydrolase
Long, J. H. (2012) · Cited by 1
Hinz, B., & Brune, K. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511642357.014 · Cited by 1
Self-citationNeuschulz, E. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3903 · Cited by 1
Paracetamol für die perioperative Analgesie: Alte Substanz – neue Erkenntnisse
Zahn, P. K., Sabatowski, R., Schug, S. A., Stamer, U. M., & Pogatzki-Zahn, E. M. (2010) · BORIS (University Library Bern) · doi:10.48350/70339
Modulation of Respiratory Tract Responses by Acetaminophen
Smith, G. J. (2015) · OpenCommons at University of Connecticut (University of Connecticut)
Mediadores envolvidos na resposta febril induzida pela RANTES
Machado, R. R. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2009.tde-13022009-160445
Schmerztherapie mit Nicht-Opioiden
Beubler, E. (2000) · Springer eBooks · doi:10.1007/978-3-7091-3779-6_3
The assessment and modification of cardiovascular risk in inflammatory arthritis
McKellar, G. (2012) · Enlighten: Theses (The University of Glasgow)
PREDNOSTI PARACETAMOLA U LIJEČENJU OSOBA S HIPERTONIJOM I ARTROZOM
Pavličević, I., Kuzmanić, M., Rumboldt, M., & Rumboldt, Z. (2011) · Acta medica Croatica
Paracetamol (acetaminophen) with or without an antiemetic for acute migraine in adults
Derry, S., Moore, R. A., & McQuay, H. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008040
Brack, A., & Schäfer, M. (2012) · Springer eBooks · doi:10.1007/978-3-642-21125-6_19 · Cited by 1
Langhendries, J.-P. (2015) · Archives de Pédiatrie · doi:10.1016/j.arcped.2015.07.003 · Cited by 1
Role of the prostaglandin pathway and the use of NSAIDs in genitourinary malignancies
Taylor, J. A., III, Pilbeam, C. C., & Nisbet, A. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.7.1125
Orata, D. O., Yusuf, A., Nineza, C., Mukabi, M., & Mbui, D. N. (2014) · IOSR Journal of Applied Chemistry · doi:10.9790/5736-07529099
“The mechanism of action is thought to be inhibition of cyclo-oxygenase (5).”
BackgroundNSAIDs applied to the skin: a very topical subject
Greener, M. (2009) · Nurse Prescribing · doi:10.12968/npre.2009.7.7.43303
Metadata
- Authors
- Hinz, B., Cheremina, O., & Brune, K.
- Affiliations
- University of Rostock (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- ORCID
- Hinz, Burkhard
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-09-20
- Volume
- 22
- Issue
- 2
- Pages
- 383-390
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2132889863
- Cited by
- 478
- References
- 51
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 15 · 2023: 14 · 2022: 19 · 2021: 19 · 2020: 14 · 2019: 28 · 2018: 33 · 2017: 29 · 2016: 35 · 2015: 49 · 2014: 28 · 2013: 33 · 2012: 36
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- paracetamol, COX-2 inhibition, COX-1 inhibition, COX-2 inhibitors, thromboxane B2, prostaglandin E2, plasma pharmacokinetics, gastrointestinal safety, cardiovascular risk, analgesic mechanism, anti-inflammatory mechanism
- MeSH terms
- Acetaminophen, Cells, Cultured, Humans, Isoenzymes, Monocytes, Time Factors, Cyclooxygenase 1, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.